[Fwd: Thimerosal-Containing DTaP linked with Speech Disorder Epidemic - New Geier Article]

[Guest guest]

Darcy

Here's one article that may help - I found it in the archives

On 18 Jan 2005 Theresa Lynn Truax wrote

Hello all,

Please read this email and follow this link to the full article.

http://www.nccn.net/~wwithin/NeuroDevelopmental Disorders Following TCVs -

A Follow-up Analysis.pdf

This says it all as far as I am concerned.

The major take-away finding in this brand new article by Geier and Geier for

all of us here are is this:

If your child was vaccinated with a thimerosal-containing DTaP vaccine, s/he

has a significantly higher chance of having a neurodevelopmental disorder --

and is significantly more likely to have developed a neurodevelopmental

disorder OTHER THAN autism, such as mental retardation, SPEECH DISORDERS,

personality disorders, and thinking abnormalities.

DAN! doctors beware -- we're coming to see you in droves now!

Best,

Theresa

__________________________

" Neurodevelopmental Disorders Following Thimerosal-Containing Childhood

Immunizations: A Follow-up Analysis "

A. Geier and Mark R. Geier,

International Journal of Toxicology (American College of Toxicology) 2004

The authors previously published the first epidemiological study from the

United States associating thimerosal from childhood vaccines with

neurodevelopmental disorders based upon assessment of the Vaccine Adverse

Event Reporting System (VAERS) database. A number of years have gone by

since their previous analysis of the VAERS. The present completely open

epidemiological study was undertaken to determine whether the previously

observed effect between thimerosal-containing childhood vaccines and

neurodevelopmental disorders rare still apparent in the VAERS as children

have had a chance to further mature and be diagnosed with

additional neurodevelopmental disorders. In the present study, a cohort of

children receiving thimerosal-containing

Diphtheria-Tetanus-acellular-Pertussis (DTaP) vaccines in comparison to a

cohort of children receiving thimerosal-free DTaP vaccines administered from

1997 through 2000 based upon an assessment of adverse events reported to the

VAERS database (online VAERS database updated through 28 February 2004) were

evaluated.

It was determined that there were significantly increased odds ratios (ORs)

for autism (OR = 1.8 p < 0.05), mental retardation (OR = 2.6, p < 0.002),

speech disorders (OR = 2.1, p < 0.02), personality disorders (OR = 2.6, p <

0.01), and thinking abnormalities (OR = 8.2, p < 0.01) reported to the VAERS

database following thimerosal-containing DTaP vaccines in comparison to

thimerosal-free DTaP vaccines. Potential confounders and reporting biases

were found to be minimal in this assessment of the VAERS. It was observed,

even though the media has reported a potential association between autism

and thimerosal exposure, that the other neurodevelopmental disorders

analyzed in this assessment of the VAERS database had significantly higher

odds ratios than autism following thimerosal-containing DTaP vaccines in

comparison to thimerosal-free DTaP vaccines.

The present study provides additional epidemiological evidence supporting

previous epidemiological, clinical and experimental evidence that

administration of thimerosal-containing vaccines in the United States

resulted in a significant number of children developing neurodevelopmental

disorders. The authors concluded,

" Despite, the recent conclusion from the National Academy of Sciences'

Institute of Medicine that there is no evidence of relationship between

thimerosal and autism, and that no further scientific research should be

undertaken to evaluate to evaluate the relationship between thimerosal and

autism, the results of the present

study, taken with data recently published by a number of researchers,

demonstrate a connection between mercury exposure via infant vaccinations

and the dramatic increase in autism and other neurodevelopmental disorders

in the United States. It is clear that the results of the present study,

mandate that additional research should be undertaken, no only for autism,

but other childhood neurodevelopmental disorders, by evaluating childhood

mercury-associated exposures, especially from thimerosal-containing

childhood vaccines. "